TMCI - Treace Medical Concepts, Inc. Stock Price, Fair Value and News

$7.47-0.23 (-2.99%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

TMCI Price Action

Last 7 days

11.9%


Last 30 days

26.8%


Last 90 days

31.1%


Trailing 12 Months

24.3%

TMCI RSI Chart

Dec2025FebMarAprMayJunJulAug102030405060708090100

TMCI Valuation

Market Cap

487.1M

Price/Earnings (Trailing)

-9.9

Price/Sales (Trailing)

2.28

Price/Free Cashflow

-16.71

TMCI Price/Sales (Trailing)

20232024202524681012

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TMCI Fundamentals

TMCI Revenue

Revenue (TTM)

213.8M

Rev. Growth (Yr)

6.6%

Rev. Growth (Qtr)

-9.86%

20202021202220232024202550M100M150M200M

TMCI Earnings

Earnings (TTM)

-49.2M

Earnings Growth (Yr)

17.96%

Earnings Growth (Qtr)

-9.27%

202020212022202320242025-60M-50M-40M-30M-20M-10M0

TMCI Profitability

Return on Equity

-50.38%

Return on Assets

-23.82%

Free Cashflow Yield

-5.98%

TMCI Investor Care

Shares Dilution (1Y)

1.58%

Diluted EPS (TTM)

-0.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20202021202220232024202520M40M60M80M100M120M140M160M180M200M220M
Net sales
YearQ1Q2Q3Q4
2025210.8M213.8M00
2024196.0M198.5M202.9M209.4M
2023155.0M167.0M174.7M187.1M
2022104.8M114.1M125.5M141.8M
202164.8M77.7M85.1M94.4M
202043.9M48.4M52.9M57.4M
201900039.4M
Get all data in R, Python etc through our Historical Stock Data APIs
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
 CEO
 WEBSITEtreace.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES423

Treace Medical Concepts, Inc. Frequently Asked Questions


What is the ticker symbol for Treace Medical Concepts, Inc.? What does TMCI stand for in stocks?

TMCI is the stock ticker symbol of Treace Medical Concepts, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Treace Medical Concepts, Inc. (TMCI)?

As of Fri Aug 22 2025, market cap of Treace Medical Concepts, Inc. is 487.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TMCI stock?

You can check TMCI's fair value in chart for subscribers.

Is Treace Medical Concepts, Inc. a good stock to buy?

The fair value guage provides a quick view whether TMCI is over valued or under valued. Whether Treace Medical Concepts, Inc. is cheap or expensive depends on the assumptions which impact Treace Medical Concepts, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TMCI.

What is Treace Medical Concepts, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Aug 22 2025, TMCI's PE ratio (Price to Earnings) is -9.9 and Price to Sales (PS) ratio is 2.28. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TMCI PE ratio will change depending on the future growth rate expectations of investors.